🇺🇸 U.S. Stock Unicorn Sniper: Cerebras Systems (Nasdaq: CBRS)

Overall Score: 82 points (full marks for asset scarcity, but heavily penalized for extremely expensive valuation)
Conclusion: 【Cautious Screening】 (Limited to first-day sentiment for IPO speculation, do not blindly chase high or bottom positions in the secondary market)
Core Logic Summary: With the grand narrative of “defeating Nvidia” and backed by OpenAI’s billion-dollar orders, its fundamentals have achieved a qualitative leap (especially with the clearance of CFIUS regulatory risks); but a valuation of $40 billion and nearly 78 times price-to-sales ratio (P/S) have thoroughly exhausted its tolerance for errors over the next two years.
Key Information: Officially filed S-1 prospectus on April 17, and today (May 4) began formal roadshow. The offering price range is expected between $115.00 and $125.00, with plans to issue 28 million shares, raising approximately $3.4 billion to $4 billion.
Capital and Market Support (Institutions and Underwriters)
This is a top-tier U.S. stock capital game, also a rapid “valuation leap.”
Wall Street’s top teams: Morgan Stanley, Citi, Barclays, and UBS jointly underwrite. The backing of these investment banks ensures strong institutional subscription levels. It is reported that the current bookbuilding has received over $10 billion in intent orders, with extremely hot oversubscription.
Capital Greed: Worth noting, Cerebras just completed Series H funding in February 2026 (only three months ago), raising $1.1 billion at a valuation of $23 billion. Yet, in just three months, the target valuation for listing has skyrocketed to $40 billion. This kind of frenzy in primary and secondary markets indicates that retail investors will face very high costs on the first day of trading.
Financials and Fundamentals (Core Data Penetration)
Compared to the version of the prospectus withdrawn at the end of 2024, this new financial data has achieved two key “risk mitigation” points:
Revenue Surge and Customer Health: Full-year 2025 revenue is projected to reach $510 million. More importantly, the previously major regulatory vulnerability—“G42 dependence”—has been significantly diluted. Previously, over 85% of revenue depended on the UAE’s G42 Group, leading to months of CFIUS (Committee on Foreign Investment in the United States) national security reviews. In the latest 2025 financial report, G42’s revenue share has dropped sharply to 24%.
Burning Money to Survive, Still Unprofitable: As a hardware chip company, wafer fabrication and R&D costs are astronomical. The company remains heavily loss-making, and as capacity ramps up, cash burn remains huge.
Business and Barriers (Main Business)
This is the “killer weapon” that allows Cerebras to win Wall Street’s approval:
Wafer-Scale Engine (WSE): Traditional AI chips (like Nvidia H100) are only the size of a postage stamp, but Cerebras takes a different approach, creating a “plate-sized” monolithic chip. By making the entire wafer into a single chip, it bypasses the biggest bottleneck in traditional GPU clusters—“data transfer latency.” When processing large models with massive parameters, its speed and efficiency deliver a significant blow to traditional architectures.
Ultimate Endorsement: In January 2026, the company signed a large-scale compute supply deal with OpenAI, valued at over $10 billion through 2028. Being able to secure real money from OpenAI as a “Plan B” outside of Nvidia in the AI arms race is the strongest proof of its underlying technological barriers.
Use of Funds (Funding Allocation)
This nearly $4 billion fundraising is very pure: it’s aimed at supply chain and next-generation R&D. In today’s TSMC (Taiwan Semiconductor Manufacturing Company) with extreme capacity shortages, Cerebras must hold massive cash reserves to compete with Nvidia and AMD for precious wafer capacity. This money is its “life-saving fund,” and a key weapon for its transition to cloud AI services (AI as a Service).
Valuation and Benchmarking (Industry Comparison)
This is the core reason for 【Cautious Screening】.
With an issuance valuation of $40 billion against projected 2025 revenue of $510 million, its static P/S ratio reaches a terrifying 78 times.
In comparison, Nvidia, which holds a monopoly and has extremely high profit margins, normally maintains a P/S ratio of only 30-40 times; similarly, AMD, as a competitor, has a much lower valuation multiple.
Hardware companies are ultimately hardware companies; a P/S of 78 indicates the market has already priced in Cerebras’ extremely perfect execution over the next 2-3 years. Under this valuation system, once listed, any slight delay in delivery or slowdown in growth could lead to a brutal “Davis double kill.”
Market Sentiment (Capital Play)
Frenzied AI Premium: The Philadelphia Semiconductor Index has continued to soar this year, with the market extremely eager for stories of “replacing Nvidia.” This sentiment will dominate the frenzy on its IPO debut.
Shareholder Play: Given the current institutional subscription enthusiasm far exceeding expectations, the IPO price is expected to be set at the upper end of the range ($125) or even raised.
Investment Bank Practical Decision:
Cerebras is a great tech company, but a $40 billion valuation makes it not a “safe” deal at this stage.
If your U.S. stock account has direct access to IPO allocations, you can leverage institutional enthusiasm to subscribe and take profits during the first-day opening surge—don’t hold the tail.
It is strongly advised not to blindly build positions in the secondary market within the first three months after listing. High-valuation hard tech stocks often experience a “valuation kill zone” around lock-up expiry or the release of their first financial report, which is a good entry point for large funds to enter calmly.
#美股 #IPO #CBRS #Artificial Intelligence #英伟达 #US Stock IPOs #WallStreet